San Francisco, CA, United States of America

Stephen Kohl Doberstein

This inventor holds 26 USPTO granted patents and 8 published patent applications, plus 8 CIPO patents and 4 EPO patents, primarily in Fc Variant Optimization. Top assignees: Xencor, Inc., Five Prime Therapeutics, Inc., Exelixis, Inc.. Active years: 2002-2019.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Stephen Kohl Doberstein. Retrieved from https://idiyas.com/inventor/stephen-kohl-doberstein

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 26 

% Patents Active = 73.1


 

Average Co-Inventor Count = 7.9

ph-index = 10

Forward Citations = 971(Granted Patents)


Location History:

  • Pasadena, CA (US) (2010)
  • San Francisco, CA (US) (2002 - 2019)

Company Filing History:


Years Active: 2002-2019

Loading Chart...
Loading Chart...
Loading Chart...
Areas of Expertise:
Fc Variants
FGFR Fusion Proteins
Disease Treatment
Polynucleotides
Cardiac Conditions
Lipid Metabolism
Insulin-like Genes
Pharmaceutical Agents
Pesticidal Agents
C. Elegans
D. Melanogaster
RGS Modulation
26 patents (USPTO):Explore Patents

Title: The Inventor Spotlight: Stephen Kohl Doberstein

Introduction

Stephen Kohl Doberstein is a prolific inventor based in San Francisco, CA, with a impressive track record of 25 patents to his name. His innovative work in the field of optimized Fc variants has made significant contributions to the world of antibodies and Fc fusions, showcasing his expertise and dedication to scientific advancements.

Latest Patents

Doberstein's latest patents include groundbreaking inventions such as "Optimized Fc variants and methods for their generation." This invention focuses on the development of optimized Fc variants, along with the methods for their generation, laying the foundation for enhanced antibodies and Fc fusions in the industry.

Career Highlights

Throughout his career, Stephen Kohl Doberstein has worked with renowned companies such as Xencor, Inc. and Five Prime Therapeutics, Inc. His collaboration with these companies has allowed him to further explore his passion for innovation and drive for creating novel solutions in the realm of biotechnology and pharmaceuticals.

Collaborations

Doberstein has had the privilege of collaborating with esteemed professionals in the field, including coworkers like Gregory Alan Lazar and Arthur J Chirino. These collaborations have not only enriched his own work but have also led to the development of impactful inventions that have the potential to shape the future of the industry.

Conclusion

In conclusion, Stephen Kohl Doberstein stands as a shining example of a visionary inventor whose dedication to scientific progress and relentless pursuit of innovation have resulted in numerous patents that have the power to transform the landscape of biotechnology. His contributions continue to inspire and pave the way for future advancements in the field.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…